Hypertension Treatment in Nigeria (HTN) Program: rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial.
Abigail S BaldridgeKasarachi Aluka-OmitiranIkechukwu A OrjiGabriel L ShedulTunde M OjoHelen EzeGrace ShedulEugenia N UgwunejiNonye B EgentiRosemary C B OkoliBoni M AleAda NwankwoSamuel OsagieJiancheng YeAashima ChopraOlutobi A SanuadePriya TripathiNamratha R KandulaLisa R HirschhornMark D HuffmanDike B OjjiPublished in: Implementation science communications (2022)
ClinicalTrials.gov NCT04158154 . The trial was prospectively registered on November 8, 2019.